Maravai Lifesciences Holdings Inc Share Price

NASDAQ: MRVI

Small Cap

$2.67

-0.12

(-4.12%)

as on September 13, 2025 at 1:29 am IST

$₹

Maravai Lifesciences Holdings Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$2.64
Day's Price Range
$2.79
$2.67
1.12%
Downside
4.49%
Upside
52 Week's Low
52 Week's High
$1.67
52-Week Price Range
$9.5
$2.67
37.64%
Downside
255.81%
Upside

Maravai Lifesciences Holdings Inc share price movements today

Previous Close: $2.79
Open: $2.77
Volume: 1.4M
Day's Low - High: $2.64 - $2.79
52 Week Low - High: $1.67 - $9.5

Maravai Lifesciences Holdings Inc Historical Returns

1 Month Return: + 2.3 %
3 Month Return: + 25.35 %
1 Year Return: -68.18 %
3 Year Return: -88.83 %
5 Year Return: 0 %

Maravai Lifesciences Holdings Inc Stock Fundamentals & Key Indicators

Check Maravai Lifesciences Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$977.3M

EPS (TTM)

-0.3001

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.33%

PE Ratio (TTM)

-9.87

Industry PE ratio

-3.8535542168674697

P/B Ratio

PEG Ratio

EBITDA

-60.2M

Revenue (TTM)

219.8M

Profit Margin

-87.57%

Return On Equity TTM

47559700.00%

Maravai Lifesciences Holdings Inc Stock Valuation

Track how Maravai Lifesciences Holdings Inc P/E has moved over time to understand its valuation trends.

Maravai Lifesciences Holdings Inc in the last 5 years

Overview
Trends

Lowest (8.75x)

December 31, 2022

Today (-9.87x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Highest (52.83x)

June 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -9.87x

Maravai Lifesciences Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Maravai Lifesciences Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Maravai Lifesciences Holdings Inc	BUY	$977.3M	NA	-9.87	-87.57%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Maravai Lifesciences Holdings Inc Stock including INR - Dollar returns

The Maravai Lifesciences Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Maravai Lifesciences Holdings Inc investment value today

Current value as on today

₹36,963

Returns

₹63,037

(-63.04%)

Returns from Maravai Lifesciences Holdings Inc Stock

₹68,176 (-68.18%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Maravai Lifesciences Holdings Inc Stock

Based on 19 analysts

BUY

78.95%

Buy

21.05%

Hold

0.00%

Sell

Based on 19 analysts, 78.95% of analysts recommend a 'BUY' rating for Maravai Lifesciences Holdings Inc. Average target price of $4.12

Maravai Lifesciences Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Maravai Lifesciences Holdings Inc.

What analysts predicted

35.19%UPSIDE

Target Price

$4.12

Current Price

$2.67

Analyzed by

19 Analysts

Target

$4.12

Maravai Lifesciences Holdings Inc target price $4.12, a slight upside of 35.19% compared to current price of $2.67. According to 19 analysts rating.

Maravai Lifesciences Holdings Inc Stock's Interest Amongst Investors

Search interest for Maravai Lifesciences Holdings Inc Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 16, 2025 to September 15, 2025

Change:-34% versus previous 30 day period

Maravai Lifesciences Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	79	68	66	74	64	73	65	56	46	47
Gross Profit	45	25	30	38	18	35	28	18	7	7
Operating Income	-2	-11	-15	0	-18	-9	-169	-38	-49	-66
EBITDA	18	5	4	684	2	9	-147	-20	-49	-66
Interest Expense	11	7	11	15	10	11	13	11	6	6
Depreciation	10	11	13	12	13	14	14	14	14	15
Income Before Tax	-4	-13	-20	656	-22	-16	-175	-46	-52	-74
Income Tax Expense	-3	-1	-5	766	0	-2	0	0	0	-4
Net Income	-1	-6	-6	-105	-12	-7	-99	-26	-29	-39
Net Profit Margin	-1.71%	-9.49%	-9.66%	-142.92%	-18.82%	-10.33%	-151.90%	-46.35%	-63.92%	-83.53%

Maravai Lifesciences Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	123	143	284	799	883	288	259
Gross Profit	63	76	204	658	714	140	108
Operating Income	16	23	119	554	574	-31	-235
EBITDA	33	48	138	585	609	712	-156
Interest Expense	27	29	30	30	20	45	47
Depreciation	22	24	25	24	38	45	56
Income Before Tax	-16	-5	81	530	551	617	-261
Income Tax Expense	0	0	2	61	60	756	-1
Net Income	-17	-5	76	182	220	-119	-144
Net Profit Margin	-14.32%	-3.63%	27.06%	22.78%	24.94%	-41.19%	-55.89%

Maravai Lifesciences Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-11	-6	-105	-12	-7	-99	-26	-29	-69
Operating Cash Flow	19	14	7	-8	17	13	-14	-9	-10
Investing Cash Flow	-24	-15	-12	-4	-6	-8	-4	-23	-3
Financing Cash Flow	-43	0	0	0	0	0	-234	-4	-1
Change in Cash	-48	0	-4	-13	11	4	-255	-37	-15

Maravai Lifesciences Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-5	78	469	490	-119	-259
Operating Cash Flow	24	152	368	535	126	7
Investing Cash Flow	-17	6	105	-267	-122	-24
Financing Cash Flow	-4	53	-159	-187	-61	-235
Change in Cash	2	211	315	80	-57	-252

Global Institutional Holdings in Maravai Lifesciences Holdings Inc

Funds	Holdings
GTCR LLC	14%
12 West Capital Management LP	8.7%
Vanguard Group Inc	8.1%
BlackRock Inc	6.63%
BRAIDWELL LP	5.8%

See all

Insights on Maravai Lifesciences Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 46.85M → 47.39M (in $), with an average increase of 1.2% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, MRVI stock has moved up by 9.4%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 143.8%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 212.3%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -26.14M → -39.59M (in $), with an average decrease of 23.4% per quarter

About Maravai Lifesciences Holdings Inc

maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate breakthrough discoveries in areas such as genomics, proteomics, and biotherapeutic development. maravai lifesciences was formed in march 2014 through a partnership with gtcr, a leading private equity firm. our mission is to build a transformative life sciences reagents company by acquiring outstanding businesses and accelerating their growth. since our founding, we have acquired four companies, each a leader in its market segment. vector laboratories has led the market for labeling and detection products used by researchers in immunohistochemistry, immunofluorescence and related techniques. tri

Organisation	Maravai Lifesciences Holdings Inc
Headquarters	10770 Wateridge Circle, San Diego, CA, United States, 92121
Industry	Commercial Services
CEO	Mr. Bernd Brust
E-voting on shares	Click here to vote

Key Management of Maravai Lifesciences Holdings Inc

Name	Title
Ms. Christine Dolan	Executive VP & GM of Cygnus Technologies
Dr. Peter Michael Leddy Ph.D.	Executive VP & Chief Administrative Officer
Mr. Bernd Brust	CEO & Director
Mr. Rajesh J. Asarpota	EVP & Chief Financial Officer
Ms. Debra Hart	Senior Director of Investor Relations
Ms. Judith A. Solecki	Chief Human Resources Officer
Mr. Robert Andrew Eckert M.B.A., MBA	Chairman of the Board
Ms. Rebecca Buzzeo	Executive VP & Chief Commercial Officer
Mr. Kurt Oreshack J.D.	Executive VP, General Counsel & Secretary
Dr. Kate E. Broderick Ph.D.	Executive Vice President

FAQs

What is Maravai Lifesciences Holdings Inc share price today?

Maravai Lifesciences Holdings Inc share price today is $2.67 as on September 13, 2025 at 1:29 am IST at the close of the market. Maravai Lifesciences Holdings Inc share today touched a day high of $2.79 and a low of $2.64.

What is the 52 week high and 52 week low for Maravai Lifesciences Holdings Inc share?

Maravai Lifesciences Holdings Inc share touched a 52 week high of $9.5 on September 19, 2024 and a 52 week low of $1.67 on April 17, 2025. Maravai Lifesciences Holdings Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $2.67,which is 71.89% down from its 52 week high and 60.36% up from its 52 week low.

What is Maravai Lifesciences Holdings Inc's market capitalisation today?

Maravai Lifesciences Holdings Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Maravai Lifesciences Holdings Inc Stock (MRVI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Maravai Lifesciences Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Maravai Lifesciences Holdings Inc Shares that will get you 0.5618 shares as per Maravai Lifesciences Holdings Inc share price of $2.67 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Maravai Lifesciences Holdings Inc Stock (MRVI) from India?

Indian investors can start investing in Maravai Lifesciences Holdings Inc (MRVI) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 1:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Maravai Lifesciences Holdings Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 1:40 pm IST). Based on Maravai Lifesciences Holdings Inc share’s latest price of $2.67 as on September 13, 2025 at 1:29 am IST, you will get 3.7453 shares of Maravai Lifesciences Holdings Inc. Learn more about fractional shares .